Skip to main content

Advertisement

SpringerLink
Log in

Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

The present study aimed to evaluate the efficacy of α-bisabolol (BISA)-based mouthwashes in the oral hygiene of patients submitted to oral and maxillofacial surgery.

Materials and methods

A randomized, controlled, triple-blind clinical trial was conducted with 30 patients, undergoing oral and maxillofacial surgery. Three types of mouthwashes were developed, based at 0.12% chlorhexidine, 0.5% BISA, and 0.12% chlorhexidine + 0.5% BISA. The patients were evaluated in the preoperative and postoperative period, divided into three groups according to the mouthwash to be used. In the postoperative period, the oral hygiene quality of the patients was evaluated through the simplified oral hygiene index; the healing of the wounds was evaluated observing the presence of suture dehiscence and/or infection, and the pain was established using the Visual Analogue Scale. The antiseptic effect of the mouthwashes was evaluated in vitro.

Results

There were no differences in the efficacy of BISA-containing mouthwashes for oral hygiene, healing, and pain, compared to chlorhexidine based at 0.12%. There were no differences in the antiseptic activity of chlorhexidine and chlorhexidine + α-bisabolol-based mouthwashes.

Conclusion

The results indicate that BISA-based mouthwashes have clinical efficacy, in the improvement of oral hygiene and wound healing, as well as in the reduction of postoperative pain.

Clinical relevance

Considering that BISA has analgesic, antimicrobial, and anti-inflammatory properties, it is relevant to evaluate the efficacy of BISA-based mouthwashes in the oral hygiene of patients undergoing oral and maxillofacial surgery, seeking a better postoperative recovery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dalben GDS et al (2008) Evaluation of sutures after immersion in nonalcoholic benzydamine hydrochloride mouthrinse by scanning electron microscopy. Clin Oral Investig 12(3):287–290

    Google Scholar 

  2. Potera C (1999) Forging a link between biofilms and disease. Science 283(5409):1837–1839

    PubMed  Google Scholar 

  3. Trimbos J, Brohim R, Van Rijssel E (1989) Factors relating to the volume of surgical knots. Int J Gynecol Obstet 30(4):355–359

    Google Scholar 

  4. Andrade IP et al (2011) Concentração inibitória mínina de antissépticos bucais em microorganismos da cavidade oral. Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research

  5. Bugno A et al (2006) Enxaguatórios bucais: avaliação da eficácia antimicrobiana de produtos comercialmente disponíveis. Revista do Instituto Adolfo Lutz (Impresso) 65(1):40–45

    Google Scholar 

  6. Bauroth K et al (2003) The efficacy of an essential oil antiseptic mouthrinse vs. dental floss in controlling interproximal gingivitis: a comparative study. J Am Dent Assoc 134(3):359–365

    PubMed  Google Scholar 

  7. Brunke E.-J. and Hammerschmidt F.-J (1985) Constituents of the essential oil of Salvia stenophylla—first identification of (+)-epi-α-bisabolol in nature, in Essential Oils and Aromatic Plants, Springer. p. 145–150

  8. Jakovlev V, Isaac O, Thiemer K, Kunde R (1979) Pharmacological investigations with compounds of chamomile ii. New investigations on the antiphlogistic effects of (-)-alpha-bisabolol and bisabolol oxides (author’s transl). Planta Med 35(2):125–140

    PubMed  Google Scholar 

  9. Jakovlev V, Von Schlichtegroll A (1969) On the inflammation inhibitory effect of (-)-alpha-bisabolol, an essential component of chamomilla oil. Arzneimittelforschung 19(4):615–616

    PubMed  Google Scholar 

  10. Kamatou GP, Viljoen AM (2010) A review of the application and pharmacological properties of α-bisabolol and α-bisabolol-rich oils. J Am Oil Chem Soc 87(1):1–7

    Google Scholar 

  11. Cavalieri E, Mariotto S, Fabrizi C, de Prati AC, Gottardo R, Leone S, Berra LV, Lauro GM, Ciampa AR, Suzuki H (2004) α-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells. Biochem Biophys Res Commun 315(3):589–594

    PubMed  Google Scholar 

  12. Leite GdO et al (2011) (−)-α-Bisabolol attenuates visceral nociception and inflammation in mice. Fitoterapia 82(2):208–211

    PubMed  Google Scholar 

  13. Maurya AK et al (2014) α-(−)-bisabolol reduces pro-inflammatory cytokine production and ameliorates skin inflammation. Curr Pharm Biotechnol 15(2):173–181

    PubMed  Google Scholar 

  14. Melo LT, Duailibe MAB, Pessoa LM, da Costa FN, Vieira-Neto AE, de Vasconcellos Abdon AP, Campos AR (2017) (−)-α-Bisabolol reduces orofacial nociceptive behavior in rodents. Naunyn Schmiedeberg’s Arch Pharmacol 390(2):187–195

    Google Scholar 

  15. Brasil, Farmacopeia Brasileira (2010) Agência Nacional de Vigilância Sanitária. Editor, Anvisa ^ eBrasília Brasília

    Google Scholar 

  16. Fones, A.C. and E.C. Kirk, Mouth hygiene, a course of instruction for dental hygienists: a text-book containing the fundamentals for prophylactic operators. 1916: Lea & Febiger

  17. Heitz F, Heitz-Mayfield L, Lang N (2004) Effects of post-surgical cleansing protocols on early plaque control in periodontal and/or periimplant wound healing. J Clin Periodontol 31(11):1012–1018

    PubMed  Google Scholar 

  18. Greene JG, Vermillion JR (1964) The simplified oral hygiene index. J Am Dent Assoc 68(1):7–13

    PubMed  Google Scholar 

  19. Souza F, Souza R, Moraes  (2016) Incorporation and release kinetics of alpha-bisabolol from PCL and chitosan/guar gum membranes. Braz J Chem Eng 33(3):453–467

    Google Scholar 

  20. Brasil, Resolução n° 466/12 sobre pesquisa envolvendo seres humanos, Ministério da Saúde : Conselho Nacional de Saúde, Editor. 2012, Ministério da Saúde Brasília

  21. Teixeira GFD, Vieira-Neto AE, da Costa FN, e Silva ARA, Campos AR (2017) Antinociceptive effect of (-)-α-bisabolol in nanocapsules. Biomed Pharmacother 91:946–950

    PubMed  Google Scholar 

  22. Barreto RS et al (2016) Evidence for the involvement of TNF-α and IL-1β in the antinociceptive and anti-inflammatory activity of Stachys lavandulifolia Vahl.(Lamiaceae) essential oil and (−)-α-bisabolol, its main compound, in mice. J Ethnopharmacol 191:9–18

    PubMed  Google Scholar 

  23. Ortiz MI, Fernández-Martínez E, Soria-Jasso LE, Lucas-Gómez I, Villagómez-Ibarra R, González-García MP, Castañeda-Hernández G, Salinas-Caballero M (2016) Isolation, identification and molecular docking as cyclooxygenase (COX) inhibitors of the main constituents of Matricaria chamomilla L. extract and its synergistic interaction with diclofenac on nociception and gastric damage in rats. Biomed Pharmacother 78:248–256

    PubMed  Google Scholar 

  24. Aron de Miranda HA et al (2010) Evaluation of the sesquiterpene (−)-α-bisabolol as a novel peripheral nervous blocker. Neurosci Lett 472(1):11–15

    Google Scholar 

  25. Simões RCS et al (2011) Avaliação in vitro da atividade antimicrobiana de enxaguatórios bucais. Rev bras odontol 68(1):91

    Google Scholar 

  26. Forrer M, Kulik EM, Filippi A, Waltimo T (2013) The antimicrobial activity of alpha-bisabolol and tea tree oil against Solobacterium moorei, a Gram-positive bacterium associated with halitosis. Arch Oral Biol 58(1):10–16

    PubMed  Google Scholar 

  27. Santos NOd et al (2015) Assessing the chemical composition and antimicrobial activity of essential oils from Brazilian plants—Eremanthus erythropappus (Asteraceae), Plectrantuns barbatus, and P. amboinicus (Lamiaceae). Molecules 20(5):8440–8452

    PubMed  PubMed Central  Google Scholar 

  28. de Lima Pérez ALA et al (2011) Atividade Antifúngica de Antissépticos Bucais sobre candida spp. Revista Brasileira de Ciências da Saúde 15(1):69–74

    Google Scholar 

  29. Defever K et al (1982) Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates. Antimicrob Agents Chemother 22(5):810–815

    PubMed  PubMed Central  Google Scholar 

  30. Hawser SP, Douglas LJ (1995) Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 39(9):2128–2131

    PubMed  PubMed Central  Google Scholar 

  31. Fischman SL (1986) Current status of indices of plaque. J Clin Periodontol 13(5):371–374

    PubMed  Google Scholar 

  32. Batista ALA, Diógenes Alves Uchôa Lins R, de Souza Coelho R, do Nascimento Barbosa D, Moura Belém N, Alves Celestino FJ (2014) Clinical efficacy analysis of the mouth rinsing with pomegranate and chamomile plant extracts in the gingival bleeding reduction. Complement Ther Clin Pract 20(1):93–98

    PubMed  Google Scholar 

  33. Silveira J, Oliveira Vd, Padilha WWN (2002) Avaliação da redução do índice de placa visível e do índice de sangramento gengival em uma prática de promoção de saúde bucal com crianças. Pesqui Odontol Bras 16(2):169–174

    PubMed  Google Scholar 

  34. Hammad H, Hammad MM, Abdelhadi IN, Khalifeh MS (2011) Effects of topically applied agents on intra-oral wound healing in a rat model: a clinical and histomorphometric study. Int J Dent Hyg 9(1):9–16

    PubMed  Google Scholar 

  35. Jesudasan JS, Wahab PA, Sekhar MM (2015) Effectiveness of 0.2% chlorhexidine gel and a eugenol-based paste on postoperative alveolar osteitis in patients having third molars extracted: a randomised controlled clinical trial. Br J Oral Maxillofac Surg 53(9):826–830

    PubMed  Google Scholar 

  36. Glowania H, Raulin C, Swoboda M (1987) Effect of chamomile on wound healing—a clinical double-blind study. Zeitschrift fur Hautkrankheiten 62(17):1262 1267-71

    PubMed  Google Scholar 

  37. Kim S, Jung E, Kim JH, Park YH, Lee J, Park D (2011) Inhibitory effects of (−)-α-bisabolol on LPS-induced inflammatory response in RAW264. 7 macrophages. Food Chem Toxicol 49(10):2580–2585

    PubMed  Google Scholar 

  38. Golan DE, Tashjian AH, Armstrong EJ (2012) Princípios de farmacologia. Grupo Gen-Guanabara Koogan

  39. Foulkes D (1973) Some toxicological observations on chlorhexidine. J Periodontal Res 8(s12):55–60

    Google Scholar 

  40. Bhatia S et al (2008) Fragrance material review on α-bisabolol. Food Chem Toxicol 46(11):S72–S76

    PubMed  Google Scholar 

  41. Ensina LF et al (2009) Reações de hipersensibilidade a medicamentos. Rev bras alerg imunopatol 32(2):42–47

    Google Scholar 

  42. Bernd LAG (2005) Alergia a medicamentos. Rev bras alerg imunopatol 28(3):125–132

    Google Scholar 

  43. US Food & Drug Administration, FDA Drug Safety Communication: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate. US Department of Health & Human Services, 2017

  44. Jacob SE, Hsu JW (2010) Reactions to Aquaphor®: is Bisabolol the culprit? Pediatr Dermatol 27(1):103–104

    PubMed  Google Scholar 

  45. Jacob SE, Matiz C, Herro EM (2011) Compositae-associated allergic contact dermatitis from Bisabolol. Dermatitis 22(2):102–105

    PubMed  Google Scholar 

  46. Pastor N, Silvestre JF, Mataix J, Lucas A, Pérez M (2008) Contact cheilitis from bisabolol and polyvinylpyrrolidone/hexadecene copolymer in lipstick. Contact Dermatitis 58(3):178–179

    PubMed  Google Scholar 

  47. Wilkinson S, Hausen B, Beck M (1995) Allergic contact dermatitis from plant extracts in a cosmetic. Contact Dermatitis 33(1):58–59

    PubMed  Google Scholar 

  48. Junior VFV, Pinto AC, Maciel MAM (2005) Plantas medicinais: cura segura. Química nova 28(3):519–528

    Google Scholar 

  49. Castilho AR, Murata RM, Pardi V (2007) Produtos Naturais em Odontologia. Revista Saúde-UNG 1(1):11–19

    Google Scholar 

Download references

Acknowledgments

The authors are thankful to the support and partnership of the Fortaleza’s Holy House of Mercy (Santa Casa da Misericórdia de Fortaleza) for having accepted and given unconditional and essential support for this research. Without this partnership, the recruitment and clinical evaluation of patients, a fundamental part of our research, would not be possible. The authors also thank the Staff of the Department of Maxillofacial Surgery of this Hospital, Dr. José Maria Sampaio Menezes Junior, Dr. Vera Araújo Magalhães, Dr. Carla Welch da Silva, Dr. Eymard Vieira Borges, Dr. George Matos Ferreira Gomes Junior, Dr. Jonas Ferreira Maciel Gusmão, Dr. Paulo Henrique Rodrigues Carvalho, and Dr. Stélio da Conceição Araújo Neto, for their support during data collection of this study.

Author information

Authors and Affiliations

  1. Dentistry Department, University of Fortaleza, Av. Washington Soares, 1321, Edson Queiroz, Fortaleza, Ceará, 60811-905, Brazil

    Bruno Frota Amora-Silva

  2. University of Fortaleza (UNIFOR), Fortaleza, Ceará, Brazil

    S. C. Ribeiro, C. L. Vieira & A. P. V. Abdon

  3. Federal University of Ceará, Fortaleza, Brazil

    F. R. Mendes, A. E. Vieira-Neto & F. N. Costa

  4. Experimental Biology Center (NUBEX), University of Fortaleza (UNIFOR), Fortaleza, Ceará, Brazil

    A. R. Campos

Authors
  1. Bruno Frota Amora-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. C. Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. L. Vieira
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. R. Mendes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. E. Vieira-Neto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. P. V. Abdon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. N. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. R. Campos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruno Frota Amora-Silva.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Statement on the welfare of animals

This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amora-Silva, B.F., Ribeiro, S.C., Vieira, C.L. et al. Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial. Clin Oral Invest 23, 577–584 (2019). https://doi.org/10.1007/s00784-018-2464-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-018-2464-4

Keywords

Search

Navigation